ACRO Biomedical

ACRO Biomedical Co., Ltd.
The new era of tissue engineering and regenerative medicine.

 

ACRO Biomedical was founded in June, 2014, and is positioning in developing and producing natural scaffold biomaterials from animal tissues and organs for the applications in tissue engineering and regenerative medicine (TERM).
We apply our proprietary super critical CO2 (SCCO2) extraction technology to remove cells, fats and non-collagenous proteins in animal tissues and organs, while keeping the intact collagen scaffolds as the biomaterials for the purposes of  tissue engineering, cell therapy and organ engineering.


Core Technology:Supercritical CO2 extraction technology;
Applications:Wound Care, Orthopedics, Dentistry, Ophthalmology, Aesthetic Surgery, Sports Medicine, CVS, Neural Surgery, etc.

Proprietary Technology
The Proprietary Technology- supercritical CO2 is used to remove cells, fats and other substances in animal organs and tissues, while keeping the undiminished collagen scaffold as the product for the high-end medical devices.
*Other animal including cow, sheep, horse can also be used.

Platform Technology
Supercritical CO2

ACRO Biomedical


ACRO Milestones
ACRO Biomedical

More infomation of ARCO Biomedical